SQL Injection Vulnerability in Dawa Pharma by Mayuri K
CVE-2023-53734

8.7HIGH

Key Information:

Vendor

Mayurik

Status
Dawa-pharma
Vendor
CVE Published:
4 December 2025

Badges

👾 Exploit Exists🟡 Public PoC

What is CVE-2023-53734?

The Dawa Pharma 1.0 software is susceptible to SQL injection attacks, which enable unauthorized users to execute arbitrary SQL queries on the backend server. This vulnerability allows potential attackers to retrieve sensitive data and may lead to unauthorized administrative access, compromising the integrity and confidentiality of the application.

Human OS v1.0:
Ageing Is an Unpatched Zero-Day Vulnerability.

Remediate biological technical debt. Prime Ageing uses 95% high-purity SIRT6 activation to maintain genomic integrity and bolster systemic resilience.

Deploy the Patch

Affected Version(s)

dawa-pharma 1.0-2022

Exploit Proof of Concept (PoC)

PoC code is written by security researchers to demonstrate the vulnerability can be exploited. PoC code is also a key component for weaponization which could lead to ransomware.

CVE-2023-53734 - Proof of Concept

References

https://www.exploit-db.com/exploits/51818
exploit
https://www.mayurik.com/source-code/P0349/best-pharmacy-b...
product
https://github.com/nu11secur1ty/CVE-nu11secur1ty/tree/mai...
productissue-tracking

CVSS V4

Score:
8.7
Severity:
HIGH
Confidentiality:
High
Integrity:
None
Availability:
None
Attack Vector:
Network
Attack Complexity:
Low
Attack Required:
None
Privileges Required:
Undefined
User Interaction:
None

Timeline

  • 🟡

    Public PoC available

  • 👾

    Exploit known to exist

  • Vulnerability published

  • Vulnerability Reserved

Credit

nu11secur1ty
JSON
.